涩里番

Marios Lange is a PhD candidate in Experimental Medicine at 涩里番, affiliated with the Lady Davis Institute. His research focuses on identifying novel epigenetic combination therapies for ovarian cancer, with an emphasis on maximizing efficacy while minimizing toxicity in preclinical models. He also investigates how the extracellular matrix contributes to tumor growth and therapeutic resistance. In addition to his research, Marios is actively engaged in trainee leadership. He currently serves as Co-Chair of both the Lady Davis Institute Trainee Committee and the RRCancer Student Committee, where he leads initiatives that support academic, professional, and community development for young scientists in cancer research.